39
Metodiche interventistiche nelle patologie cardiache congenite Gianfranco Butera Policlinico San Donato IRCCS

12 g butera metodiche interventistiche

Embed Size (px)

Citation preview

Metodiche interventistiche nelle patologie cardiache congenite  

Gianfranco  Butera  Policlinico  San  Donato  IRCCS  

What  is  fetal  interven.on?  

•  Fetal  interven7on  is  reaching  inside  the  uterus  to  help  a  fetus  who  has  a  problem.    

•  All  fetal  interven7on  is  really  maternal-­‐fetal  interven7on  

Focus is on defects which can be accurately identified antenatally and

which cause progressive and permanent damage to the fetus if

not corrected.

Michael Tynan and Lindsey Allan

256

Balloon dilatation of the aortic valve in the fetus:

a report of two cases

Darryl Maxwell, Lindsey Allan, Michael J Tynan

AbstractBecause they had irreversible damage to

the left ventricular myocardium none of

12 patients with critical aortic stenosis

diagnosed prenatally survived after

postnatal treatment. This experience

prompted three attempts at intrauterine

balloon dilatation of the aortic valve in

two fetuses with this condition. On each

attempt the balloon catheter was

successfully delivered to the left ventri-

cle. In the first fetus the aortic valve was

not crossed and the fetus died the next

day. In the second fetus the balloon was

correctly positioned across the aortic

valve and inflated in the valve ring. After

delivery, a further balloon angioplasty

was performed; this relieved the stenosis

but the patient died five weeks later from

persisting left ventricular dysfunction

related to endocardial fibroelastosis.

Balloon angioplasty is feasible in fetal

life but the prognosis depends on the

ability of the relief of stenosis to limit,

prevent, or allow regression of left

ventricular damage before delivery.

Department ofFetal Medicine,Guy's Hospital,LondonD MaxwellDepartment ofPerinatal Cardiology,Guy's Hospital,LondonL AllanDepartment ofPaediatric Cardiology,Guy's Hospital,LondonM J TynanCorrespondence to

Dr Lindsey Allan,Department of Perinatal

Cardiology, 15th Floor,Guy's Hospital, St Thomas's

Street, London SEI 9RT.

Accepted for publication22 January 1991

The mildest forms of congenital aortic

stenosis may become haemodynamically

important only in late adult life when calcifica-

tion becomes a prominent feature whereas the

most severe forms are life threatening in

infancy. In the neonate mortality is high and

left ventricular dysfunction with endocardial

fibroelastosis is common. Even when the

obstruction to the left ventricular outflow tract

is relieved the left ventricle often fails to

maintain cardiac output.

Recently, it has become possible to detect

both aortic stenosis and the severer forms of

endocardial fibroelastosis in fetal life. In our

unit, 28 fetuses were identified as having aortic

stenosis alone (two cases) or aortic stenosis

with endocardial fibroelastosis (26 cases). In

two of the 12 mothers who elected to continue

the pregnancy there was an intrauterine death.

None of the 10 livebirths survived; only four

survived long enough for treatment by balloon

dilatation of the aortic valve. In addition, we

saw another prenatal feature that influenced

the outcome. In four of the 28 fetuses, the left

ventricle failed to grow normally as gestation

advanced and the left ventricle became hypo-

plastic which made the neonate unsuitable for

relief of aortic valve obstruction.'

Balloon dilatation is a well established

technique for the relief of pulmonary or aortic

Br Heart J 1991;65:256-8

stenosis in children.23 Its efficacy in the new-

born is being compared with that of surgical

valvotomy.4 We attempted balloon dilatation

in the fetus in an attempt to improve the

dismal prognosis for this condition by

relieving obstruction to the aortic valve before

irreversible left ventricular damage had

developed and to try to prevent the growth

failure that we had seen. We report our

experience in two fetuses in whom balloon

dilatation of the aortic valve was attempted.

Patients and methodsBoth patients were referred to the Department

of Perinatal Cardiology after a four chamber

view of the heart in the local hospital indicated

an abnormality. They were examined by an

Advanced Technical Laboratories Mark 4

sector scanner and a Hewlett Packard 77020A

phased array scanner with 5 MHz transducers.

Both machines can be used for Doppler

evaluation of intracardiac velocities and the

Hewlett Packard 77020A can be used for colour

flow mapping.The parents were extensively counselled

about the experimental nature of the

procedures to be attempted. The therapeutic

procedures were performed in the Fetal

Medicine Unit at Guy's Hospital with an

Acuson 128 ultrasound system for visualisation

of the needle course and manipulation of the

guide wires and balloon catheters. Eighteen

gauge transabdominal chorionic villus sam-

pling needles were used (Rockett, London).

For needle puncture of the umbilical cord and

cardiac chambers we used a freehand ultra-

sound guided method adapted from the tech-

nique first described by Daffos et al.' The

maternal skin was infiltrated by local anaes-

thetic before each needle insertion. Intra-

uterine and intracardiac pressures were

measured by a sterile system of fluid-filled

tubing connected from the hub ofthe needle via

a solid state transducer to a Siemans Mingograf

by a previously described method.6 In the first

procedure we used a USCI coronary balloon

catheter, diameter 2-5 mmwhen inflated. In the

second case a 3-5 mm diameter balloon was

custom made by NuMed.

CASE 1This 23 year old woman (para 2) was initially

referred at 22 weeks' gestation. The left

ventricle was of normal size for the gestation

but was contracting poorly. There was little

discernible forward flow into the left ventricle

or aorta. The left ventricular wall showed

• 12 fetuses, 27-33 weeks, 8 isolated AS, 2 AA, 2 PS+AS • 7/8 Pts with isolated AS – technically successful • 4 died within 24 hours of fetal intervention • 6 died after postnatal therapy • 2 survivors

• One had procedure at 33 weeks (dilated LV - would not have developed HLHS?)

• One survivor – procedure was technically unsuccessful

Aim  of  Fetal  Cardiac  Interven.ons  

1)  Promote  ventricular  growth  and  func7on  •  Univentricular    Biventricular  circula7on  

•  Aor7c  stenosis  with  evolving  HLHS  •  Pulmonary  stenosis  or  atresia  and  evolving  HRHS  

2)  Improve  survival  •  HLHS  with  intact  atrial  septum  •  Salvage  procedures  (e.g.  hydrops)  

•  Fetal  pacing  for  complete  heart  block?  

The  most  common  fetal  cardiac  interven7on  procedure  is    AORTIC  VALVULOPLASTY  

The  primary  indica7on  for  fetal  aor7c  valvuloplasty  is  to  alter  the  in  utero  natural  

history  of  midgesta7on  fetal  aor7c  stenosis  with  evolving  HLHS  

HLHS  

Selec.on  Guidelines  for    Fetal  Aor.c  Valvuloplasty  

3  POINTS  

1.  The  dominant  cardiac  anatomic  anomaly  is  valvar  aor7c  stenosis    

2.  Evolving  HLHS    3.  There  is  poten7al  for  a  technically  successful  

procedure  and  biventricular  outcome  postnatally.  

1.   The  dominant  cardiac  anatomic  anomaly  is  valvar  aor.c  stenosis  

with  ALL  of  the  following:    – Decreased  mobility  of  valve  leaflets  – Antegrade  Doppler  color  flow  jet  across  aor7c  valve  smaller  than  the  valve  annulus  diameter  

– No  or  minimal  subvalvar  LV  ouWlow  obstruc7on    

Selec.on  Guidelines  for    Fetal  Aor.c  Valvuloplasty  

2.  Evolving  HLHS    

–  LV  func7on  qualita7vely  depressed              AND  

–  EITHER  retrograde  or  bidirec7onal  flow  in  the  transverse  aor7c  arch  (between  the  first  2  brachiocephalic  vessels)  at  any  7me  during  the  cardiac  cycle  

– OR  two  of  the  following:  •  Monophasic  MV  inflow  (Doppler  profile  of  MV  inflow  without  discrete  E  and  A  waves),    

•  Le\-­‐to-­‐right  flow  across  atrial  septum  or  intact  atrial  septum  (bulging  le\  to  right),    

•  Bidirec7onal  flow  in  pulmonary  veins  

Selec.on  Guidelines  for    Fetal  Aor.c  Valvuloplasty  

3.  There  is  poten.al  for  a  technically  successful  procedure  and  biventricular  outcome  postnatally  

1  point  for  each  of  the  following:  •  LV  long  axis  Z-­‐score  >  0  •  LV  short  axis  Z-­‐score  >  0  •  Aor7c  anulus  Z-­‐score  >  -­‐3.5  •  Mitral  valve  anulus  Z-­‐score  >  -­‐2  •  Mitral  valve  or  aor7c  stenosis  maximum  gradient  ≥  20  mmHg  

A  score  ≥4  had  100%  sensi7vity,  53%  specificity,  38%  posi7ve  predic7ve  value,  and  100%  nega7ve  predic7ve  value.  

Selec.on  Guidelines  for    Fetal  Aor.c  Valvuloplasty  

Fetal  angioplasty  

•  Maternal  conscious  seda7on  and  regional  spinal  blockade  conducted  by  an  anesthesiologist.    

•  An  appropriate  fetal  lie  is  achieved  by  external  version.    •  Maternal  posi7oning  is  kept  with  le\  uterine  displacement.    •  To  promote  uterine  relaxa7on  mothers  are  given  nifedipine  

20  mg  TID  for  48-­‐72  hours,  star7ng  12-­‐24  hours  before  the  procedure.  

•  If  ideal  fetal  posi7oning  cannot  be  agained  by  external  manipula7on,  the  procedure  should  be  abandoned.    

•  A\er  op7mal  fetal  posi7on  is  achieved,  the  fetus  is  anesthe7zed  using  a  mixture  of  fentanil  (5-­‐10  micrograms/kg),  pancuronium  (10-­‐20  micrograms/Kg)  and  atropine  (20  micrograms/kg)  given  intramuscularly  or  in  the  umbilical  chord  using  a  21-­‐22G  Chiba  needle.    

•  Cardiac  access  is  agained  through  direct  needle  puncture  of  the  fetal  heart  via  the  uterus  and  the  fetal  chest  wall.    

•  Under  con7nuous  two-­‐dimensional  ultrasound  guidance  a  15-­‐cm-­‐long  17-­‐to-­‐18-­‐gauge  Chiba  needle  (with  a  stylet)  is  advanced  to  the  target  

•  The  imaging  plane  is  carefully  adjusted  to  yield  a  picture  in  which  both  the  en7re  needle  length  and  the  target  cardiac  chamber  are  included  in  the  field  of  view    

Fetal  angioplasty  

•  The  Ventricle  is  entered  at  the  apex,  with  the  needle  course  parallel  to  the  ouWlow  track  directed  at  the  steno7c/atre7c  semilunar  valves.    

•  In  this  way  the  valves  can  be  crossed  almost  blindly,  with  minimal  wire  and  catheter  manipula7on.    

•  A\er  stylet  removal,  the  catheter  system  is  introduced  and  advanced  un7l  the  sha\  mark  reaches  the  proximal  hub  of  the  needle.    

•  Balloon  posi7oning  for  infla7on  is  based  on  the  external  aforemen7oned  measurements  and  ultrasound  imaging,  with  emphasis  given  to  the  visualiza7on  of  the  guide  wire      

Fetal  angioplasty  

•  Balloons  are  inflated  with  pressure  gauges  to  allow  precise  es7mates  of  infla7on  diameters.    

•  Balloon  diameters  10-­‐30%  larger  than  the  aor7c  or  pulmonary  valve  annulus  are  selected  for  valve  dila7on.    

•  Two  to  four  infla7ons  are  performed  depending  on  the  fetal  clinical  status.  

•  A\er  dilata7on,  the  whole  system  (needle  +  balloon  +  wire)  is  withdrawn  as  a  unit  through  the  fetal  cardiac  wall  and  out  of  the  fetal  and  maternal  bodies  to  avoid  shearing  off  the  balloon  from  the  catheter  sha\.      

Fetal  angioplasty  

•  A  pre-­‐marked  system  (a  rapid  exchange  10  mm  long  coronary  balloon  pre  mounted  over  a  cut-­‐off  0.014”  floppy  7p  guide  wire)  is  advanced  to  the  desired  loca7on.    

•  The  needle,  guide  wire,  and  balloon  sha\s  are  premeasured  and  marked  so  that  posi7oning  within  the  fetal  heart  is  known  from  external  measurements  rather  than  the  ultrasound  imaging  alone.    

•  The  balloon  sha\  is  marked  with  sterile  tapes  so  that  no  more  than  the  full  length  of  the  balloon  is  extruded  out  of  the  Chiba  needle  7p  when  fully  advanced.    

•  The  wire  is  also  fixed  with  sterile  tapes  so  that  no  more  than  3-­‐4  cm  of  the  distal  flexible  wire  straight  7p  extruded  out  from  the  balloon  7p.    

Fetal  angioplasty  

Fetal  angioplasty  

Fetal  Interven7on  for  AS  Aor7c  Regurgita7on  

•  Agempted  procedures  n=92  •  Technically  successful  71/92  (77%)  •  Aor7c  regurgita7on    

– None  1/3,  mild  1/3,  mod-­‐severe  1/3  •  Fetuses  with  mod-­‐severe  were  younger  •  Larger  BAR  associated  with  more  severe  AR  (>1.2)    •  AR  had  no  associa7on  with  fetal  demise  •  85%  were  born  with  none  or  mild  AR  

•  48%  Technically  successful  and  live  born  have  achieved  a  biventricular  repair  

1.  Bradycardia  (40%)  –  treatable  2.  Hemopericardium  requiring  drainage  3.  Balloon  rupture  –  resolves  4.  Moderate-­‐severe  AR  (40%)  –  resolves  5.  Peri-­‐procedural  fetal  demise  (10%)  

Complications

Mizrahi-Arnaud A - Pediatric Research 2007

Fetal  Aor.c  Regurgita.on  

Antegrade  flow   Aor7c  regurgita7on  

Results 2  Ventricle  1  Ventricle  Unsuccessful  

Mean±SD  Z  scores  of  the  aor.c  annulus  (A),  MV  annulus  (B),  LV  short  axis  (C),  and  LV  long  axis  (D)  at  the  .me  of  prenatal  interven.on  and  at  the  latest  follow-­‐up  fetal  echocardiogram  aXer  technically  

successful  interven.on  and  comparison  fetuses  (control).  

McElhinney D B et al. Circulation. 2009;120:1482-1490

Summary  In  utero  balloon  aor.c  valvuloplasty  

•  AR occurred in 63% of our fetuses after BAV (44/69 technically successful)

•  AR resolved completely in 73% who had AR (28/38 live-born)

•  AR grade improved among the remaining 7/10 patients who had any residual AR at birth

•  2 patients had moderate or severe AR at birth and one had mild AR

Fetal  AR  

1.  Why  does  fetal  AR  appear  to  be  well  tolerated?  1.  Low  systemic  resistance  –  placenta  

2.  High  LVEDP  in  fetus  with  AS  –  mi7gates  the  degree  of  AR  

3.  RV  is  providing  circulatory  support  

2.  Why  does  AR  improve  post-­‐BAV?  1.  Unique  hemodynamics  result  in  less  mechanical  stress  

on  the  valve  

2.  Fetal  valves  are  dynamic,  contain  prolifera7ng  cells  with  an  immature  phenotype    

3.  Underlying  pathologic  stenosing  process  

Personal  experience  

•  2  cases  

•   24  Weeks  GA  

•  Detec7on  at  22  WGA  

•  Pa7ents  should  have  a  prenatal  echocardiographic  diagnosis  of  PA/IVS  or  cri7cal  pulmonary  stenosis  with  the  following  features:      

•  membranous  pulmonary  atresia,  with  iden7fiable  pulmonary  valve  (PV)  leaflets  or  membrane,    

•  no  or  minimal  systolic  opening,    •  and  no  or  minimal  color  Doppler  ultrasound  flow  across  the  pulmonary  valve  (PV);    

•  an  intact  ventricular  septum;    •  le\-­‐to-­‐right  shun7ng  across  a  patent  ductus  arteriosus  (PDA);    

Pulmonary  atresia/IVS  and  evolving  hypoplas.c  right  heart  syndrome  

•  Pa7ents  should  have  a  prenatal  echocardiographic  diagnosis  of  PA/IVS  with  the  following  features:      

•  right  heart  hypoplasia,  with  a  tricuspid  valve  (TV)  annulus  Z  score  below  <  2  and  an  iden7fiable  but  qualita7vely  small  right  ventricle  (RV)    

•  with  no  evidence  of  RV  growth  a\er  2-­‐4  weeks  of  serial  echocardiographic  evalua7on.    

•  Cases  with  fetal  diagnosis  of  major  coronary-­‐to-­‐RV  fistulas  should  be  excluded.  Pulmonary  valvuloplasty  is  performed  between  24  and  30  weeks’  gesta7on.    

Pulmonary  atresia/IVS  and  evolving  hypoplas.c  right  heart  syndrome  

Pulmonary  atresia/IVS  

Tricuspid  Valve  Z-­‐score  >  -­‐3  at  mid-­‐  and  late  fetal  echo  is  an  indicator  of  biventricular  repair    

Pulmonary  atresia/IVS  

1.  Bradycardia  (40%)  –  treatable  

2.  Hemopericardium  requiring  drainage  

3.  Balloon  rupture  –  resolves  

4.  Moderate-­‐severe  PR    –  resolves  

5.  Peri-­‐procedural  fetal  demise  (10%)  

Tworetzky  W,  McElhinney  DB,  Marz  GR,  Benson  CB,  Brusseau  R,  Morash  D,  Wilkins-­‐Haug  LE,Lock  JE,  Marshall  AC.  In  utero  valvuloplasty  for  pulmonary  atresia  with  hypoplasMc  right  ventricle:  techniques  and  outcomes.  Pediatrics.  2009  Sep  124(3):e510-­‐8.  

10  cases  reported  (GA  21-­‐28  weeks).  Success  60%.  Fetuses  who  underwent  successful  interven7ons  were  older  (range:  23–28  weeks;  median:  26  weeks).  

The  procedure  on  the  right  ventricle  is  more  challenging  

due  to:  the  more  complex  RV  geometry,  the  smaller  size  of  

the  right  ventricle  compared  to  the  le\,  and  the  fact  that  

RVOT  is  behind  the  sternum.  

Atrial  septostomy  in  HLHS  

Atrial  septostomy  in  HLHS  

Limita.ons/Failures  of  Fetal  Interven.ons  

1)  Technical  limita7ons  •  Fetal  posi7oning    •  Fetal  stabiliza7on  /  movement  

•  Imaging  •  Equipment  inadequacies  

2)  Biological  limita7ons  

•  No  animal  model  •  Late  referral  

•  Pa7ent  selec7on  •  No  uniform  postnatal  approach  

Thank  you  for  your  agen7on